Senate health committee Chair Bernie Sanders (I-VT) said he will introduce legislation that would prevent pharmaceutical companies from charging more in the United States than they do in comparable countries -- a bill that Sanders said if enacted would dramatically reduce the cost of popular obesity drugs and other prescriptions. The expected legislation may be similar to a rule former President Donald Trump tried to implement while in office to lower the cost of Medicare Part B drugs and a...